The authors made an error in analysis, with SNPs being mapped to human genome build hg18 and genes to human genome build hg19. Consequently, there are errors in [Table 5](#pgen.1005127.t001){ref-type="table"}, [S15 Table](#pgen.1005127.s001){ref-type="supplementary-material"}, and the accompanying text on pages 9 and 11. Corrected text and tables are provided here.
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###### QTL candidate gene SNPs associated with aggressive prostate cancer in CGEMS GWAS.

![](pgen.1005127.t001){#pgen.1005127.t001g}

  Chr.       Candidate Gene   SNP Distance From Gene (bp)   SNP          PLCO Variable        Odds Ratio (95% C.I.)   Minor Allele Frequency   t stat   *P* value   Permutation *P* value   
  ---------- ---------------- ----------------------------- ------------ -------------------- ----------------------- ------------------------ -------- ----------- ----------------------- ----------
  5q31.1     ***CXCL14***     0                             rs2547       pros_gleason_prost   0.61 (0.43-0.85)        0.054                    0.033    -2.889      0.004                   0.003
                              0                             rs2237061    pros_gleason_prost   0.61 (0.43-0.88)        0.048                    0.030    -2.685      0.007                   0.008
                              19118                         rs10515473   pros_gleason_prost   0.72 (0.59-0.88)        0.163                    0.122    -3.148      0.002                   0.002
                              24155                         rs4463175    pros_gleason_prost   1.42 (1.12-1.81)        0.087                    0.101    2.878       0.004                   0.003
                              69386                         rs801564     pros_stage_n         1.05 (1.01-1.09)        0.001                    0.282    2.587       0.010                   0.010
                              92585                         rs2067000    pros_stage_n         1.05 (1.02-1.09)        0.001                    0.288    2.883       0.004                   0.004
  6p22.1     *PGBD1*          76094                         rs1233708    pros_stage           1.08 (1.02-1.13)        0.042                    0.213    2.921       0.004                   0.003
  6p22.2     *HIST1H2AB*      59345                         rs1800562    pros_gleason         1.40 (1.16-1.70)        0.025                    0.041    3.459       0.001                   0.001
                              79097                         rs933199     pros_gleason         0.75 (0.62-0.92)        0.032                    0.025    -2.759      0.006                   0.007
  6p22.3     *GPLD1*          43164                         rs811103     pros_gleason_prost   1.32 (1.09-1.60)        0.186                    0.195    2.855       0.004                   0.005
                              56546                         rs793663     pros_gleason_prost   1.32 (1.09-1.60)        0.186                    0.195    2.854       0.004                   0.006
  6q15       *AKIRIN2*        0                             rs4707385    pros_gleason         1.16 (1.05-1.29)        0.135                    0.164    2.909       0.004                   0.003
             *ORC3*           0                             rs6930600    pros_gleason         0.86 (0.78-0.95)        0.246                    0.222    -3.095      0.002                   0.002
                              0                             rs7755167    pros_gleason         0.86 (0.78-0.95)        0.246                    0.221    -3.107      0.002                   0.002
                              0                             rs7772351    pros_gleason         1.14 (1.04-1.26)        0.164                    0.193    2.768       0.006                   0.007
                              0                             rs9450765    pros_gleason         1.17 (1.06-1.29)        0.171                    0.202    3.118       0.002                   0.002
                              43692                         rs7757636    pros_gleason         0.86 (0.79-0.95)        0.246                    0.222    -3.089      0.002                   0.003
                              96943                         rs9450716    pros_gleason         1.16 (1.05-1.28)        0.161                    0.189    3.042       0.002                   0.002
  9p13.3     *CCL19*          70925                         rs3802427    pros_stage_m         1.09 (1.04-1.15)        0.000                    0.162    3.557       3.89E-04                1.00E-04
             *CCL21*          75161                         rs277606     pros_gleason_prost   1.35 (1.11-1.65)        0.179                    0.187    2.986       0.003                   0.002
             *KIAA1045*       68052                         rs10123308   pros_gleason_prost   1.30 (1.08-1.57)        0.212                    0.216    2.773       0.006                   0.006
  9p21.2     *MOB3B*          0                             rs868856     pros_stage           0.94 (0.89-0.98)        0.064                    0.215    -2.748      0.006                   0.006
                              0                             rs868856     pros_stage_t         2.02 (1.34-3.04)        0.191                    0.088    3.371       0.001                   0.001
                              0                             rs3739530    pros_gleason         0.80 (0.70-0.93)        0.075                    0.056    -2.996      0.003                   0.004
                              0                             rs4879515    pros_stage_t         1.68 (1.16-2.41)        0.320                    0.130    2.784       0.005                   0.005
                              0                             rs7046653    pros_stage_t         2.01 (1.34-3.02)        0.192                    0.088    3.346       0.001                   0.001
                              0                             rs7046653    pros_stage           0.94 (0.89-0.98)        0.064                    0.216    -2.707      0.007                   0.007
                              0                             rs10121765   pros_gleason_prost   0.77 (0.64-0.93)        0.260                    0.209    -2.776      0.006                   0.005
                              6547                          rs2814707    pros_stage_t         2.09 (1.38-3.19)        0.162                    0.075    3.458       0.001                   0.001
                              13431                         rs3849942    pros_stage_t         2.15 (1.41-3.28)        0.161                    0.075    3.564       3.80E-04                0.001
                              31199                         rs774359     pros_stage_t         1.99 (1.32-3.01)        0.176                    0.079    3.284       0.001                   0.001
                              64176                         rs1853186    pros_stage           0.94 (0.90-0.98)        0.079                    0.272    -2.730      0.006                   0.006
  16p11.2    ***ITGAX***      55680                         rs8045738    pros_gleason_prost   1.33 (1.08-1.62)        0.141                    0.148    2.753       0.006                   0.005
  16q12.2    ***LPCAT2***     0                             rs10521319   pros_stage_m         1.11 (1.03-1.20)        0.000                    0.057    2.619       0.009                   0.009
                              86077                         rs9302667    pros_gleason_prost   1.35 (1.11-1.64)        0.156                    0.170    2.994       0.003                   0.003
                              98065                         rs893260     pros_gleason_prost   1.30 (1.07-1.58)        0.175                    0.184    2.679       0.007                   0.006
  20p11.21   *GZF1*           52836                         rs6076072    pros_stage           0.90 (0.84-0.97)        0.028                    0.075    -2.914      0.004                   0.003
                              52836                         rs6076072    pros_stage_t         2.17 (1.21-3.92)        0.068                    0.035    2.589       0.010                   0.009
  20p13      *NSFL1C*         22006                         rs6042568    pros_gleason         0.75 (0.62-0.90)        0.037                    0.029    -3.007      0.003                   0.004

The third paragraph of the section 'Analysis of Human Prostate Cancer GWAS Data Reveals That QTL Candidate Gene SNPs Are Associated with Aggressive Prostate Cancer' should read:

In the study, 1,372 SNPs mapped within a 100 kb radius of the 29 QTL candidate genes were tested in the CGEMS cohort. Analysis of aggressive vs. non-aggressive disease phenotypes were performed as per the comparisons described in Table 4. Correction for multiple testing was performed using permutation testing (n = 10,000 permutations). Fourteen of the 29 candidate genes exhibited evidence for association with clinical characteristics of aggressive prostate cancer ([Table 5](#pgen.1005127.t001){ref-type="table"}). Most notably, SNPs in three of the five genes associated with poor clinical outcomes in TCGA (Provisional) and GSE21032 prostate cancer gene expression datasets (*CXCL14*, *ITGAX*, and *LPCAT2*) were all associated with aggressive prostate cancer: For *CXCL14*, the following SNPs were associated with Gleason score at prostatectomy: rs2547 (permutation *P* = 0.003; OR = 0.61 \[0.43--0.85\]), rs2237061 (permutation *P* = 0.008; OR = 0.61 \[0.43--0.88\]), rs10515473 (permutation *P* = 0.002; OR = 0.72 \[0.59--0.88\]), and rs4463175 (permutation *P* = 0.003; OR = 1.42 \[1.12--1.81\]); and the following with metastasis to regional lymph nodes: rs801564 (permutation *P* = 0.010; OR = 1.05 \[1.01--1.09\]) and rs2067000 (permutation *P* = 0.004; OR = 1.05 \[1.02--1.09\]). For *ITGAX*, an association was apparent between rs8045738 and Gleason score at prostatectomy (permutation *P* = 0.005; OR = 1.33 \[1.08--1.62\]). Finally, for *LPCAT2*, rs10521319 was associated with distant metastasis (permutation *P* = 0.009; OR = 1.11 \[1.03--1.20\]), and rs9302667 (permutation *P* = 0.003; OR = 1.35 \[1.11--1.64\]) and rs893260 (permutation *P* = 0.006; OR = 1.30 \[1.07--1.58\]) with Gleason score at prostatectomy. Manhattan plots for all relevant genomic regions are shown in S5 Fig. Additionally, haplotypes in LD with these three QTL candidate genes were associated with clinical markers of prostate cancer aggressiveness ([S15 Table](#pgen.1005127.s001){ref-type="supplementary-material"}).
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###### Statistically significant aggressive disease-associated haplotypes for QTL candidate genes in the CGEMS prostate cancer cohort.
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Click here for additional data file.
